NCCN Annual Conference

NCCN Annual Conference
The NCCN (National Comprehensive Cancer Network) Annual Conference attracts more than 1600 registrants from across the United States and the globe, including oncologists, oncology fellows, nurses, pharmacists, and other healthcare professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology, the data upon which the guidelines are based, and quality initiatives in oncology.
May 19, 2018
Lee Newcomer, MD, MHA, private consultant, discusses the differences between UnitedHealthcare's pilot episodic payment model and CMS models.
May 02, 2018
Social determinants of health are being carefully tended to in the Medicare populations, explained Lee Newcomer, MD, MHA, private consultant.
March 27, 2018
On the closing day of the National Comprehensive Cancer Network (NCCN) 23rd Annual Conference in Orlando, Florida, Bijal Shah, MD, of Moffitt Cancer Center, presented on acute lymphoblastic leukemia (ALL), and on the lessons learned from the application of chimeric antigen receptor (CAR) T-cell therapy in this indication.
March 26, 2018
The use of immune checkpoint inhibitors has revolutionized the treatment of cancer, said John A. Thompson, MD, of the Fred Hutchinson Cancer Research Center and the Seattle Cancer Care Alliance, but “With this good news has come some not so good news”: immune-related adverse events can cause serious harm to patients receiving these drugs.
March 24, 2018
At the National Comprehensive Cancer Network (NCCN) 23rd Annual Conference, held March 22-24 in Orlando, Florida, Sharon H. Giordano, MD, MPH, the University of Texas MD Anderson Cancer Center; Anthony D. Elias, MD, University of Colorado Cancer Center; and William J. Gradishar, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, provided an update on the NCCN guidelines for the treatment of breast cancer and discussed new directions in breast cancer therapy.
March 24, 2018
During a Friday session of the National Comprehensive Cancer Network 23rd Annual Conference in Orlando, Florida, Cliff Goodman, PhD, of the Lewin Group, moderated a multi-stakeholder panel discussion on delivering and receiving cancer care in value-based care models.
March 23, 2018
The second day of the National Comprehensive Cancer Network (NCCN) 23rd Annual Conference in Orlando, Florida, opened with a dual keynote presentation on transforming cancer care in the United States.
March 23, 2018
Sharing data and a collaborative relationship are 2 best practices from commercial payers participating in the Oncology Care Model, according to Ron Kline, MD, FAAP, of the Center for Medicare and Medicaid Innovation.
March 23, 2018
Sidedness matters for metastatic disease, and right-sided colon cancer has been known for a shorter time than left-sided colon cancer, making the right-sided version more difficult to treat, explained Alan Venook, MD, of the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center.
March 23, 2018
“Even though we have all these fancy, effective drugs,” said Shaji K. Kumar, MD, “supportive care still plays an important role in multiple myeloma.”
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.